MAY 03, 2016 6:59 PM PDT

Aerobic respiration helps gut pathogens fluorish

WRITTEN BY: Kerry Evans
Antibiotics cure infections, right? Well, not always. A new study published in Cell Host & Microbe details how antibiotics can select for the growth of pathogenic bacteria in the gut.

Researchers from UC Davis found that antibiotics create a niche within the gut that helps pathogens like Salmonella flourish. Essentially, antibiotics wipe out the “good” bacteria living in the gut. These bacteria help us break down complex carbohydrates in dietary fiber, producing butyrate. Butyrate is taken up by intestinal epithelial cells and used to convert oxygen to carbon dioxide. Without the butyrate-producing bacteria, oxygen escapes into the intestinal lumen, creating an ideal environment for pathogenic Salmonella to grow.

According to study author Andreas Baumler, “Unlike Clostridia and other beneficial microbes in the gut, which grow anaerobically, or in the complete absence of oxygen, Salmonella flourished in the newly created oxygen-rich microenvironment after antibiotic treatment … in essence, antibiotics enabled pathogens in the gut to breathe”.
 
Antibiotics help Salmonella compete with gut flora.
The group showed that Salmonella coupled aerobic and nitrate respiration to grow in the guts of streptomycin-treated mice. They constructed a mutant that lacked the ability to use oxygen and nitrate and found that its fitness was severely compromised - after 4 days of infection, nearly 2,000-fold more wild type Salmonella were recovered compared to the mutant. Interestingly, similar numbers of the wild type and mutant cells were recovered from mice that had not been treated with streptomycin. This suggests that the ability to use oxygen and nitrate for respiration contributed to the so-called “post-antibiotic pathogen expansion”.

Interestingly, a decrease in the number of butyrate-producing bacteria has been linked to inflammatory bowel disease. Butyrate was found to decrease the production of proinflammatory cytokines in the gut by inhibiting the activity of NF-κB. Similarly, one study found that butyrate increased the number of T regulatory cells in the gut, possibly alleviating inflammation. According to study author Hiroshi Ohno, “butyrate is natural and safe as a therapy and in addition to that it is cheap, which could reduce costs for both patients and society”.
 

Sources: UC Davis, Cell Host & Microbe, Gut, Science 2.0
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAR 31, 2020
Microbiology
MAR 31, 2020
Researchers Suggest Repurposing Pancreatitis Drug to Treat COVID-19
As SARS-CoV-2 upends normalcy in the world, researchers are trying to find a treatment for the illness it causes.
APR 06, 2020
Microbiology
APR 06, 2020
Sensor Can Quickly Detect Bacterial Contamination in Water
Bacterial runoff is a serious threat to our waterways and oceans; pathogenic microbes are known to contaminate stormwate ...
APR 24, 2020
Microbiology
APR 24, 2020
How Syphilis Evades the Immune System
The incidence of syphilis has been rising for the past two decades, and over 115,000 new cases were diagnosed in the US ...
MAY 06, 2020
Cell & Molecular Biology
MAY 06, 2020
SARS-CoV-2 Can Infect Intestinal Cells
Once thought to cause symptoms that primarily affect the respiratory system, there has been evidence that the virus can ...
MAY 09, 2020
Clinical & Molecular DX
MAY 09, 2020
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem.
MAY 18, 2020
Microbiology
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
Loading Comments...